Kenny J. Watson

466 total citations
10 papers, 342 citations indexed

About

Kenny J. Watson is a scholar working on Pharmacology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Kenny J. Watson has authored 10 papers receiving a total of 342 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmacology, 3 papers in Infectious Diseases and 3 papers in Epidemiology. Recurrent topics in Kenny J. Watson's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Kenny J. Watson is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Pharmacogenetics and Drug Metabolism (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Kenny J. Watson collaborates with scholars based in United States and United Kingdom. Kenny J. Watson's co-authors include Hannah M. Jones, Iain Gardner, Ming Xu, Vikas Kumar, Phil Stanley, Parul Patel, Natilie Hosea, David R. Plowchalk, Maurice Dickins and Barry Jones and has published in prestigious journals such as Clinical Pharmacology & Therapeutics, Toxicology and Applied Pharmacology and Clinical Pharmacokinetics.

In The Last Decade

Kenny J. Watson

9 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kenny J. Watson United States 7 124 108 79 75 51 10 342
Henry Pertinez United Kingdom 14 97 0.8× 101 0.9× 94 1.2× 76 1.0× 31 0.6× 31 495
James B. Mangold United States 15 206 1.7× 154 1.4× 172 2.2× 167 2.2× 44 0.9× 26 645
G. Mahr Germany 10 168 1.4× 223 2.1× 81 1.0× 112 1.5× 49 1.0× 20 498
Jun Yi Shi China 15 102 0.8× 177 1.6× 89 1.1× 50 0.7× 105 2.1× 45 563
M J Hauer United States 9 178 1.4× 209 1.9× 96 1.2× 104 1.4× 52 1.0× 17 551
Colin Garner United Kingdom 11 90 0.7× 61 0.6× 79 1.0× 83 1.1× 19 0.4× 15 318
Aroonrut Lucksiri Thailand 11 119 1.0× 154 1.4× 41 0.5× 73 1.0× 25 0.5× 22 354
Fabien Lamoureux France 14 81 0.7× 85 0.8× 89 1.1× 41 0.5× 19 0.4× 40 523
Ricardo Nalda‐Molina Spain 11 30 0.2× 105 1.0× 102 1.3× 126 1.7× 23 0.5× 25 437
C. Souppart Switzerland 15 147 1.2× 175 1.6× 117 1.5× 105 1.4× 24 0.5× 24 706

Countries citing papers authored by Kenny J. Watson

Since Specialization
Citations

This map shows the geographic impact of Kenny J. Watson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenny J. Watson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenny J. Watson more than expected).

Fields of papers citing papers by Kenny J. Watson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenny J. Watson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenny J. Watson. The network helps show where Kenny J. Watson may publish in the future.

Co-authorship network of co-authors of Kenny J. Watson

This figure shows the co-authorship network connecting the top 25 collaborators of Kenny J. Watson. A scholar is included among the top collaborators of Kenny J. Watson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenny J. Watson. Kenny J. Watson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Plock, Nele, Akshita Chawla, Seth Robey, et al.. (2022). Accelerating model-informed decisions for COVID-19 vaccine candidates using a model-based meta-analysis approach. EBioMedicine. 84. 104264–104264. 9 indexed citations
2.
Li, Cheryl, Kenny J. Watson, Shining Wang, Paul M. Diderichsen, & Neeraj Gupta. (2022). Population Pharmacokinetics of Mivavotinib (TAK‐659), a Dual Spleen Tyrosine Kinase and FMS‐Like Tyrosine Kinase 3 Inhibitor, in Patients With Advanced Solid Tumors or Hematologic Malignancies. The Journal of Clinical Pharmacology. 63(3). 326–337. 1 indexed citations
3.
Plock, Nele, Akshita Chawla, Seth Robey, et al.. (2021). 1010. Cross-Species Translation of Correlates of Protection for COVID-19 Vaccine Candidates Using Quantitative Tools. Open Forum Infectious Diseases. 8(Supplement_1). S595–S596.
4.
McFadyen, Lynn, Kenny J. Watson, Todd Riccobene, et al.. (2021). Population Pharmacokinetic Modeling and Probability of Pharmacodynamic Target Attainment for Ceftazidime‐Avibactam in Pediatric Patients Aged 3 Months and Older. Clinical Pharmacology & Therapeutics. 111(3). 635–645. 21 indexed citations
5.
Patel, Parul, Mallika Lala, Kenny J. Watson, et al.. (2019). Population Pharmacokinetic Analysis for Imipenem–Relebactam in Healthy Volunteers and Patients With Bacterial Infections. CPT Pharmacometrics & Systems Pharmacology. 8(10). 748–758. 45 indexed citations
6.
Trifilieff, Alexandre, Brian Ethell, David A. Sykes, et al.. (2015). Comparing the cardiovascular therapeutic indices of glycopyrronium and tiotropium in an integrated rat pharmacokinetic, pharmacodynamic and safety model. Toxicology and Applied Pharmacology. 287(1). 9–16. 4 indexed citations
7.
Watson, Kenny J., William Gorczyca, John P. Umland, et al.. (2011). Pharmacokinetic–pharmacodynamic modelling of the effect of Moxifloxacin on QTc prolongation in telemetered cynomolgus monkeys. Journal of Pharmacological and Toxicological Methods. 63(3). 304–313. 29 indexed citations
8.
Jones, Hannah M., Iain Gardner, Wendy T. Collard, et al.. (2011). Simulation of Human Intravenous and Oral Pharmacokinetics of 21 Diverse Compounds Using Physiologically Based Pharmacokinetic Modelling. Clinical Pharmacokinetics. 50(5). 331–347. 79 indexed citations
9.
Watson, Kenny J., John D. Davis, & Hannah M. Jones. (2011). Application of Physiologically Based Pharmacokinetic Modeling to Understanding the Clinical Pharmacokinetics of UK-369,003. Drug Metabolism and Disposition. 39(7). 1203–1213. 12 indexed citations
10.
Jones, Hannah M., Iain Gardner, & Kenny J. Watson. (2009). Modelling and PBPK Simulation in Drug Discovery. The AAPS Journal. 11(1). 155–166. 142 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026